Twitter Facebook LinkedIn YouTube

New Listing: Mind Cure Health (CSE:MCUR)

Video Platform Video Management Video Solutions Video Player

Mind Cure Health is a mental health and wellness company with a mission to identify, develop and commercialize products that ease suffering, increase productivity, and enhance mental health.

Additional Information:

Company: Mind Cure Health
Website: http://www.MindCure.com
Stock Symbol: CSE: MCUR
Date Published: Sep 21, 2020
Transcript: Available

Video Transcript:

I’m Megan Edwards for Investmentpitch Media

Mind Cure Health, a mental health and wellness company with a mission to identify, develop and commercialize products that ease suffering, increase productivity, and enhance mental health, is one of the latest new listings on the Canadian Securities Exchange, trading under the symbol “MCUR”.

The company closed an over-subscribed IPO, raising gross proceeds of $2,990,000 from the placement of 14,950,000 shares priced at $0.20 per share.

The shares are trading at $0.35

Haywood Securities acted as agent for the offering.

Philip Tapley, President, and CEO, stated: "We are excited to quickly commence with building our senior operational and product management team, enhance and accelerate our marketing plan, and expedite our efforts to identify and evaluate new potential product candidates in addition to our Moonbeam Mushrooms product line. I am gratified by the overwhelming investor interest in the Company and our mission that has allowed us to increase the size of the Offering and hit the ground running."

Mind Cure's initial products are a branded line of organic mushroom nootropics.

Mind Cure is developing a line of organic, functional mushroom products that will be sold online and in retail stores.

Functional Mushrooms are a rich source of antioxidants and may offer cognitive, digestive and immunity benefits as well as aid in boosting energy levels.

Reishi, Chaga, and Turkey Tail can be added to products like coffee and cocoa.

Turkey Tails are mild enough to be added to soups and broths.

The demand for functional mushroom products has rapidly increased over the past 24 months and is projected to continue strong growth through 2026.

Mind Cure’s founding team and advisors have deep and industry-specific experience in bio tech, life sciences, new product discovery, research, technology and entrepreneurship.

The company also believes that the psychedelic mushroom products market is a significant business opportunity and may take part in this emerging sector.

For more information, please visit the company’s website www.MindCure.com, contact Philip Tapley, President and CEO, at 888-593-8995 or by email at ptapley@mindcure.com

I’m Megan Edwards for Investmentpitch Media